On 5 December 2025, our Institute hosted a seminar as part of its ongoing series, featuring Dr. Mingxuan Song (宋明軒) from Suzhou Institute of Biomedical Engineering and Technology. The session, titled “Integration and Development Trends of Mainland Medical Device Industry with Next-Generation AI Technology”, and hosted by Prof. Songnan Qu.
Dr. Mingxuan Song, currently serves as the Secretary-General of the CAS Advanced Medical Device Industry Incubation Alliance. He holds the positions of Chairman and General Manager of Suzhou CAS Medical Device Industry Development Co., Ltd.—the only directly invested medical device incubation company under China Holdings Group of the Chinese Academy of Sciences (CAS)—and concurrently acts as President of the Group Corporation of the Suzhou Institute of Biomedical Engineering and Technology (SIBET), CAS.
During the lecture, Dr. Mingxuan Song provided a systematic analysis of the current state, driving forces, challenges, and future strategic development directions of the deep integration between the medical device industry in Mainland China and new-generation artificial intelligence (AI) technology，also addressed audience concerns regarding regulations for AI in medical diagnostics, explaining the ongoing development of the regulatory framework to ensure safety and foster innovation.
